Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Atorvastatin calcium propylene glycol
Drug ID BADD_D00183
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID Not Available
MeSH ID Not Available
PubChem ID 51039411
TTD Drug ID Not Available
NDC Product Code Not Available
Synonyms Not Available
Chemical Information
Molecular Formula C69H76CaF2N4O12
CAS Registry Number 1040350-07-9
SMILES CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC =C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=C C=CC=C4.CC(CO)O.[Ca+2]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Nausea07.01.07.001--
Neck pain15.03.04.009--
Neuropathy peripheral17.09.03.003--Not Available
Nightmare19.02.03.003--Not Available
Pain in extremity15.03.04.010--
Pancreatitis07.18.01.001--
Pyrexia08.05.02.003--
Rhabdomyolysis15.05.05.002--
Stevens-Johnson syndrome23.03.01.007; 12.03.01.014; 11.07.01.005; 10.01.03.020--
Tendon rupture15.07.01.008; 12.01.07.003--Not Available
Tinnitus17.04.07.004; 04.04.01.002--
Toxic epidermal necrolysis23.03.01.008; 12.03.01.015; 11.07.01.006; 10.01.01.006--
Urinary tract infection11.01.14.004; 20.08.02.001--
Urticaria23.04.02.001; 10.01.06.001--
Vision blurred17.17.01.010; 06.02.06.007--
White blood cells urine positive13.13.02.004--Not Available
Muscle fatigue15.05.03.006--Not Available
Transaminases increased13.03.01.015--Not Available
Blood alkaline phosphatase increased13.04.02.004--
Hepatic enzyme increased13.03.01.019--Not Available
The 2th Page    First    Pre   2    Total 2 Pages